⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ELTX News
Elicio Therapeutics, Inc. Common Stock
Elicio Therapeutics Announces Pricing of $15 Million Registered Direct Offering
globenewswire.com
ELTX
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Elicio Therapeutics, Inc. (ELTX) and Encourages Investors to Learn More About the Investigation
accessnewswire.com
ELTX
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Elicio Therapeutics, Inc. - ELTX
accessnewswire.com
ELTX
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Elicio Therapeutics, Inc. - ELTX
globenewswire.com
ELTX
Bronstein, Gewirtz & Grossman, LLC Is Investigating Elicio Therapeutics, Inc. (ELTX) And Encourages Stockholders to Connect
accessnewswire.com
ELTX
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Elicio Therapeutics, Inc. - ELTX
accessnewswire.com
ELTX
Elicio Therapeutics, Inc. (ELTX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation
accessnewswire.com
ELTX
Elicio Therapeutics Added to Russell 2000® and Russell 3000® Indexes
globenewswire.com
ELTX
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Elicio Therapeutics, Inc. (ELTX) and Encourages Stockholders to Learn More About the Investigation
accessnewswire.com
ELTX
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Elicio Therapeutics, Inc. - ELTX
accessnewswire.com
ELTX